Pharminent

Updated NSCLC Guidelines Incorporate PD-L1 Testing and Molecular Assays

http://www.onclive.com/publications/oncology-live/2017/vol-18-no-11/updated-nsclc-guidelines-incorporate-pdl1-testing-and-molecular-assays

Filed under: Cancer, Immunotherapy